CHDR Annual Report 2024
Contents 2024
  • Homepage
  • 2024 in perspective
  • Developing drugs
  • Developing methods
  • Developing people
  • 2024 stories
Other years

Developing methods

Developing precise, data-rich methods for early clinical drug research is one of the unique aspects of CHDR’s work. 2024 saw new developments in methods for neurology, immunology, infectious diseases, and more.

Pharmacology as the cornerstone of a multidisciplinary approach to psychedelic therapies

Studies involving healthy study participants can provide useful information in immuno-oncology

Expanding the applications for immunological challenge models

Biomarkers for neurodegenerative diseases

Machine learning to unlock insights from deep phenotyping data

NeuroKit®: developing a portable version of the NeuroCart®

Trial@home: promising results in clinical practice

Viral infection model successfully implemented

Controlled human infection models for influenza and chikungungya

Developing and validating biomarkers for chronic pain

CHDR develops measurements for fatty liver disease and weight reduction

Back to homepage
  • © CHDR 2026
  • +31 (0)71 5246400
  • info@chdr.nl
  • www.chdr.nl